€7.20
4.92% today
L&S, Jul 02, 07:09 pm CET
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Scholar Rock Holding Corp. Share price

$8.13
-1.35 14.24% 1M
-10.67 56.76% 6M
-10.67 56.76% YTD
+0.74 10.01% 1Y
-21.40 72.47% 3Y
-7.37 47.55% 5Y
-7.37 47.55% 10Y
Nasdaq, Closing price Mon, Jul 01 2024
-0.20 2.40%
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Key metrics

Market capitalization $648.40m
Enterprise Value $470.10m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 3.55
Turnover (TTM) Turnover $0.00
EBIT (operating result TTM) EBIT $-189.21m
Free cash flow (TTM) Free cash flow $-152.02m
Cash position $238.43m
EPS (TTM) EPS $-2.20
P/E ratio expected negative
Short interest 37.98%
Show more

Is Scholar Rock Holding Corp. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

Scholar Rock Holding Corp. Share analysis

Unlock Scores for Free

Analyst opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

9x Buy
100%

Analyst opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

Buy
100%

Financial data from Scholar Rock Holding Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
- -
-
100%
- Direct costs 0.60 0.60
76% 76%
-
-0.60 -0.60
76% 76%
-
- Selling and administrative expenses 15 15
79% 79%
-
- Research and development costs 43 43
56% 56%
-
-58 -58
52% 52%
-
- Depreciation and amortization 0.60 0.60
76% 76%
-
EBIT (operating result) EBIT -58 -58
44% 44%
-
Net profit -57 -57
44% 44%
-

Figures in millions USD.

Don't miss a thing! We will send you all news about the Scholar Rock Holding Corp. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Scholar Rock Holding Corp. Share News

Neutral
Business Wire
8 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the first participants were dosed in the Phase 2 EMBRAZE proof-of-concept trial, design...
Neutral
Business Wire
14 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 96,700 s...
Neutral
Business Wire
29 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced encouraging data from its Phase 1 DRAGON proof-of-concept trial of SRK-181, a selective inhi...
More Scholar Rock Holding Corp. News

Company profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Head office United States
CEO Jay Backstrom
Employees 150
Founded 2012
Website www.scholarrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today